A higher prevalence of hypertension and hyperlipidemia was observed in the lower serum ATGL groups compared to those with higher ATGL levels (48 [81.36%] vs. 37 [62.71%] vs. 30 [50.85%] vs. 21 [35.59%]). This evidence concerns the gene PNPLA2 and hyperlipidemia.